Illustration of a prescription medication bottle and white capsules representing the nationwide propranolol recall over possible metal contamination.

US Blood Pressure Pill Recall: Check Lot PK25110035

UNITED STATES, November 17, 2026 — Breckenridge Pharmaceutical has recalled a batch of blood pressure medication across the United States after warning that the capsules may contain metal fragments capable of causing internal injuries.

The voluntary recall, announced Monday, November 16, affects one lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, manufactured by Adare Pharma Solutions. The medication was distributed nationwide to wholesalers and pharmacies between October 26 and November 4, 2026.

Patients taking propranolol are being urged to check their prescription packaging and contact their healthcare provider if their medication matches the recalled lot.

Blood Pressure Medication Recall 2026: Check the Lot Number

The recall covers 60 mg extended-release capsules packaged in 100-count bottles. Breckenridge identified the following product details:

Product DetailsRecalled Medication
MedicationPropranolol Hydrochloride Extended-Release Capsules, USP
Strength60 mg
ManufacturerAdare Pharma Solutions
DistributorBreckenridge Pharmaceutical
Package100-count bottle
NDC51991-817-01
Lot NumberPK25110035
ExpirationMay 2029
DistributionOctober 26–November 4, 2026

According to the medication’s official labeling, the 60 mg capsules are white and marked “60” on the cap and “RD203” on the body. However, appearance alone cannot determine whether a capsule belongs to the recalled lot.

Patients whose pharmacy bottles do not show the lot number should ask their pharmacist to verify it.

Possible Metal Fragments Raise Internal Injury Concerns

Breckenridge said the recalled batch shared intermediate manufacturing material with another lot in which metal contamination was detected. That separate lot was never released to the market.

According to the company’s official recall announcement, affected capsules could potentially cause cuts to soft tissues in the mouth, esophagus, stomach or intestines.

Breckenridge reported no adverse events assessed as related to the recall at the time of its announcement.

The company has not disclosed the number of bottles distributed or identified specific pharmacy chains receiving the medication.

What Patients Taking Propranolol Should Do

Breckenridge advises consumers to stop using capsules from the affected lot, contact their physician or healthcare provider immediately for replacement instructions, and return unused medication to the dispensing pharmacy.

However, patients should arrange replacement treatment promptly because suddenly stopping propranolol can cause serious cardiovascular complications.

  • Check the prescription for lot PK25110035.
  • Contact the pharmacy if the lot number is missing.
  • Do not take additional capsules from the recalled lot.
  • Seek prompt medical advice and arrange a replacement.
  • Return unused affected capsules to the pharmacy.
  • Seek medical attention for suspected medication-related injuries.

Severe abdominal pain, vomiting blood, black or bloody stools, chest pain or breathing difficulties require urgent medical attention.

What Is Propranolol Used For?

Propranolol is a beta-blocker used to lower blood pressure and heart rate. Extended-release capsules may be prescribed for hypertension, angina, migraine prevention and certain heart conditions.

The current recall is limited to one identified lot of 60 mg capsules. Other propranolol strengths and formulations were not included in the company’s announcement.

Other Blood Pressure Drug Recalls in 2026

The latest warning follows separate recalls involving medications used to manage hypertension.

Earlier this year, nearly 16,000 bottles of amlodipine and olmesartan tablets were recalled after the medication failed dissolution specifications, raising concerns about whether patients would receive the intended therapeutic effect.

Another recall involved 11,460 bottles of chlorthalidone blood pressure tablets following a similar quality-testing failure.

Unlike those recalls, the Breckenridge action involves possible physical contamination rather than problems with medication dissolution.

Recall Contact Number and FDA Reporting

Breckenridge has designated Qualanex to handle recall inquiries. Consumers can call 1-855-736-0807 or email recall@qualanex.com, Monday through Friday, between 9 a.m. and 5 p.m. Eastern Time.

Suspected adverse reactions or product-quality problems can be reported through the FDA’s MedWatch program or by calling 1-800-332-1088 for reporting assistance.

The recall is being conducted with the FDA’s knowledge. As of the November 17 reporting, the company’s announcement identified only lot PK25110035, with an expiration date of May 2029.

Add Swikblog as a preferred source on Google

Make Swikblog your go-to source on Google for reliable updates, smart insights, and daily trends.

Get the Swikblog App
Stay updated with breaking news, trending stories and the latest updates—all in one place.
Get the Swikblog app on Google Play
Free download for Android devices

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *